In our monthly nutra regulatory round-up, we look at the latest regulatory status of vitamin K2 in South Korea, American ginseng and eight other Chinese medicinal herbs in China, and sports nutrition products in Australia.
COVID-19 patients with low vitamin K status tend to have worse outcomes, according to preliminary results of a study conducted by researchers in the Netherlands.
Kappa Bioscience is venturing into the vitamin K2 milk category in China, on top of its existing vitamin K2 nutraceutical business, after its synthetic-origin vitamin K2 MK-7 (menaquinone-7) was approved by China authorities for use in mother and children...
Norwegian firm Kappa Bioscience recently received approval for a drug import licence to India for its proprietary vitamin K2 ingredient, K2VITAL DELTA — the first such licence of its kind.
There has been a ‘disturbing growth’ in the incidence of low-energy bone fractures in healthy children and adolescents, a group of researchers wrote in a new review, arguing that insufficiency of vitamin D, vitamin K, and calcium are among leading considerations.
Four-week supplementation with vitamin K2 MK-7 (menaquinone-7) significantly improves vascular calcification (VC), according to a new study published in BMC Nephrology.
